Reset filter

8-ANZCA-Prescription-strong-(Schedule-8)-opioid-use-and-misuse-in-Australia-submission-FINAL

PS01(PM) Statement regarding the use of opioid analgesics in patients with chronic non-cancer pain

Statement regarding the use of opioid analgesics in patients with chronic non-cancer pain

PS12(PM)BP Position Statement on the use of ketamine in the management of CNCP Background paper

2023 Lennard Travers Professorship Guide

Guidelines for applying for the 2023 Lennard Travers Professorship

ANZCA Strategic Plan 2023-2025

The ANZCA Strategic Plan 2023-2025 guides our college-wide business activity. It's the result of comprehensive consultation and engagement within the ANZCA community and beyond.

Draft clinical governance framework

College feedback on the New Zealand Health Quality and Safety Commission’s draft clinical governance framework.

2024 WA ACE Country Conference program and registration

Program and registration form for the 2024 WA ACE Country Conference, Contemplation - Learning from experience in obstetrics.

ESWG Final report June 21.docx

2023 FPM Symposium HCI Prospectus

2023 FPM Symposium HCI prospectus 23.08.22

Auditing prescribing and dispensing rates

Assessing the use of modified-release opioid analgesics within the facility is key to working towards compliance with Quality Statement 5 of the ACSQHC Clinical Care Standard (CCS1). Obtaining information and prescribing data on medication use is the first step of achieving co...

First  < Prev   ... 71 72 73 74 75 76 77 78 79 80 ...   Next >  Last Pages: 75 of 99